Due to regulatory restrictions regarding the distribution of financial research, this report is restricted to a specific region or investor type. Get access to exclusive reports by answering the questions below.
This combination of email and password didn't match our records. Your account might not be activated. If so, please click on the link we sent you via email. You can also request a password reset or a new activation email using the links below.
MORE FILTERS
Q2'24 estimates up on strong guidance - continues to outperform. ABGSCe ‘25 EBITDA 46% above cons. TP of NOK 449 (427) – BUY.
EBIDTA of USD 65m (ABGSCe at 65m, cons at 64m). Strong guidance, ~32% above cons Q2'24 EBITDA. Stock up 2-4% relative to peers
We make only minor adjustments to our estimates. ABGSCe 33% above cons. EBITDA for 2025e. TP of NOK 112 (108) – BUY reiterated.
DHT's Q1 report much as expected. Q2 guidance slightly above ABGSCe. BUY, TP of USD 16 (15).
EBITDA USD 287m (-5% vs. ABGSC, -4% vs. cons.). 5% upside to cons. Q2'24 EBITDA. Share to trade flat vs. peers.
Q1e and Q2e down, long-term reiterated. ABGSCe ‘25 EBITDA 46% above cons. TP of NOK 427 (422) – BUY
Near-term estimates down, adding NBs to our estimates. 69% above cons '25e EBITDA. BUY, TP of USD 15
Minor adjustments. ABGSCe 34% above cons. EBITDA for 2025e. TP of NOK 108 (107) – BUY reiterated.
Strong guidance – lifting Q1 estimates. ABGSC '25e EBITDA of USD 1,121m (+39% vs. cons.). TP of DKK 314 (276) – BUY.
Adj. EBITDA of USD 206m (-9% vs. ABGSCe, -7% vs cons.). Solid mid FY'24 guidance, ~13% upside to cons Q1 EBITDA. Q4 below expectations, strong FY'24 guidance.
Q1'24e up, long-term estimates reiterated. ABGSCe 38% above cons. net profit for 2025e. TP of NOK 107 (104) – BUY reiterated.
EBITDA USD 235m (-1% vs. ABGSC, -3% vs. cons.). Strong Q1'24 guidance. Share to trade up 1-3% vs. peers.
Q1'24 estimates up, long-term reiterated. ABGSCe ‘25 EBITDA 40% above cons. TP of NOK 422 (398) – BUY.
Q1'24 down on guidance, long-term reiterated. ABGSC +75% vs. cons '25e EBITDA. BUY, TP NOK 330 (315).
Q4 EBITDA of USD 198m (0% vs. ABGSCe, -8% vs. cons). Q1e guidance below expectations. Share to trade down 1-3% vs. peers.
EBIDTA of USD 44.2m (ABGSCe at 44.3m, cons at 44.7m). Strong guidance, ~10% above cons Q1'24 EBITDA. Stock up 1-3% relative to peers.
DHT's Q4 report much as expected. Q1 guidance slightly above ABGSCe. BUY, TP of USD 15 (14.4).
All but VLCC rates are already at or close to ATH. Fleet growth will remain miniscule in '24-'25e. Average total return of ~70% in 2023, but more to come.
Low fleet growth is guaranteed throughout 2025. Q4 TCE pre-announced - ABGSC 80% above cons. for '25e. BUY, TP of USD 14.4 (16.2).
Low fleet growth is guaranteed throughout 2025. ABGSC '25e EBITDA of USD 1,113m (+31% vs. cons.). TP of NOK 276 (275) – BUY.
Save your current filters as a new Interest
Would you like to receive real-time email alerts when a new report is published under this interest?
These search results will show up under 'Saved searches' in the left panel
Would you like to receive real-time email when a new report matches this search?
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.